Betta Pharmaceuticals Co.,Ltd — Investor Relations & Filings
Betta Pharmaceuticals Co.,Ltd. focuses on the research, development, and commercialization of innovative oncology medications. The organization specializes in targeted therapies, particularly for the treatment of lung cancer and other solid tumors. Its portfolio includes Icotinib, a small-molecule EGFR tyrosine kinase inhibitor, and Ensartinib, an ALK inhibitor designed for non-small cell lung cancer. The company operates a comprehensive R&D infrastructure dedicated to molecular biology, medicinal chemistry, and clinical development. By prioritizing precision medicine, the firm aims to deliver high-quality therapeutic solutions that address complex oncological challenges. Its pipeline encompasses a diverse range of candidates, including small molecules and biologics, aimed at improving patient outcomes through advanced scientific innovation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 第四届监事会第十八次会议决议公告 | 2025-02-24 | Chinese | |
| 关于2025年日常关联交易预计的公告 | 2025-02-24 | Chinese | |
| 关于盐酸恩沙替尼胶囊启动欧洲药品管理局新药上市审批程序的公告 | 2025-02-13 | Chinese | |
| 关于BPI-452080片获得临床试验批准通知书的公告 | 2025-02-05 | Chinese | |
| 关于股东股份质押变动的公告 | 2025-01-23 | Chinese | |
| 关于股东股份质押变动的公告 | 2025-01-21 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
8 filings
| |||||
| 37809804 | 第四届监事会第十八次会议决议公告 | 2025-02-24 | Chinese | ||
| 37809791 | 关于2025年日常关联交易预计的公告 | 2025-02-24 | Chinese | ||
| 37809765 | 关于盐酸恩沙替尼胶囊启动欧洲药品管理局新药上市审批程序的公告 | 2025-02-13 | Chinese | ||
| 37809749 | 关于BPI-452080片获得临床试验批准通知书的公告 | 2025-02-05 | Chinese | ||
| 37809734 | 关于股东股份质押变动的公告 | 2025-01-23 | Chinese | ||
| 37809723 | 关于股东股份质押变动的公告 | 2025-01-21 | Chinese | ||
| 37809715 | 关于股东股份质押变动的公告 | 2025-01-13 | Chinese | ||
| 37809704 | 关于投资杭州瑞普晨创科技有限公司的进展公告 | 2025-01-03 | Chinese | ||
|
2024
7 filings
| |||||
| 37809693 | 关于股东股份质押变动的公告 | 2024-12-26 | Chinese | ||
| 37809689 | 关于股东股份质押变动的公告 | 2024-12-20 | Chinese | ||
| 37809685 | 关于盐酸恩沙替尼胶囊获美国FDA批准上市的公告 | 2024-12-19 | Chinese | ||
| 37809681 | 关于股东股份质押变动的公告 | 2024-12-18 | Chinese | ||
| 37809678 | 中信证券股份有限公司关于贝达药业股份有限公司使用部分闲置募集资金暂时补充流动资金的核查意见 | 2024-12-11 | Chinese | ||
| 37809676 | 上海荣正企业咨询服务（集团）股份有限公司关于贝达药业股份有限公司2023年限制性股票激励计划调整及预留授予相关事项之独立财务顾问报告 | 2024-12-04 | Chinese | ||
| 37809670 | 监事会关于2023年限制性股票激励计划预留授予激励对象名单（预留授予日）的核查意见 | 2024-12-04 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Betta Pharmaceuticals Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55541/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55541 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55541 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55541 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55541}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Betta Pharmaceuticals Co.,Ltd (id: 55541)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.